SCLX — Scilex Holding Share News
0.000.00%
- $19.96m
- $108.45m
- $30.25m
Brief: Scilex Holding Company Announces Completion Of Commercial Manufacturing Of Gloperba®, Expecting U.S. Launch In The First Quarter Of 2024
Files Prospectus Related To Resale From Time To Time Up To 13.5 Million Shares Of Common Stock By Selling Stockholders
Brief: Scilex Holding Company Announces Production Increase, Product Availability For Elyxyb
Brief: Scilex Holding Company Announces Issuance Of A Second New Patent In The U.S. For Ztlido
Brief: Scilex Holding Company Announces Issuance Of New Patent In The U.S.
Brief: Scilex Reaches Agreement With FDA On Path Forward To Advance Clinical Development Of Sp-102
Brief: Scilex Holding Company Announces Positive Type C Meeting With The FDA And Reaches Agreement
Drugmaker Scilex gains after H.C. Wainwright initiates coverage with 'buy'
Brief: Sclx Stock Acquisition JV Llc Reports 39.3% Stake In Scilex Holding Company As Of September 21
Brief: Scilex Holding Co Says State Of Indiana Medicaid Will Add Elyxyb As A Preferred Agent To Its Preferred Drug List Effective October 1, 2023
On September 20, Elizabeth Czerepak, CFO Of Scilex Holding Company Resigned From Company, Effective Immediately
Brief: Virpax Pharmaceuticals Updates On Litigation
Brief: Scilex Holding Says On August 30, 2023, Bankruptcy Court Entered An Order Approving Oramed Transaction
Brief: Oramed Pharmaceuticals Inc-On August 4 Entered Non-Binding Term Sheet With Sorrento Therapeutics
Brief: Sorrento Announces Launch Of Voluntary Offering To Dividend Short Holders
Brief: Sorrento Therapeutics' Bankruptcy Court Approves Elective Offering Of Restricted Common Stock Of Scilex Holding Company For Dividend Short Holders
Brief: Scilex Says On July 5, Bankruptcy Court Entered Interim Order Approving Junior Dip Facility Between Sorrento, Scintilla, Co On Interim Basis
Brief: Scilex Holding Co Says Total Product Gross Sales For Quarter Ended June 2023 Were In Range Of $39 Mln To $40 Mln
Brief: Scilex Holding Co Says On June 27, Co And Unit Entered Into A Credit Agreement With Ecapital Healthcare